The Patent Finder

Red Mountain Med Spa, LLC

11 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Aug 2033
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 5, 2027
    The maintenance fee for Sublingual Semaglutide-BPC 157 combination for weight loss (US 11,833,189) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
  • 1 fee due Jul 23, 2027
    The maintenance fee for Metabolism enhancing compositions (US 11,878,007) comes due Jul 23, 2027. Unpaid by Jan 24, 2028, it lapses early.
  • 1 fee due Aug 13, 2027
    The maintenance fee for Appetite suppressant compositions and methods thereof (US 11,896,598) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,877,902Formulations and methods for weight loss and body contouring
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,029,320Formulations and methods for weight loss and body contouring
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,344,556Appetite suppressant compositions and methods thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,896,598Appetite suppressant compositions and methods thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,303,514Immediate and controlled release appetite suppressant compositions for weight loss
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,878,007Metabolism enhancing compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,310,931Sublingual phentermine spray compositions and day-night appetite suppression and weight loss regimen using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,310,932Sublingual phentermine spray compositions and day-night appetite suppression and weight loss regimen using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,551,470Metabolism Enhancing Compositions
In force
 · Low confidence
In forceLow confidence
US 11,833,189Sublingual Semaglutide-BPC 157 combination for weight loss
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited